Sinovac Biotech Ltd., of Beijing, reported that Nasdaq has granted the company an exemption from a listing rule to allow it extra time to file its 2016 annual report on form 20-F while it conducts an internal investigates into complaints lodged against the company and its sales practices and policies. The market extended the deadline for complying with the rule until Oct. 30.